Skip to content

CASI

CASI Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.15
+3.08%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-85.3%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 9, 2022Zukiwski Alexander A · officer: EVP and Chief Medical OfficerA-Award3,000$15
Sep 8, 2022Huang James · director: Purchase33,300$4.28
Sep 2, 2022Huang James · director: Purchase400$3.74
Aug 26, 2022Huang James · director: Purchase39,527$3.75
Aug 23, 2022Huang James · director: Purchase40,000$3.50
Jun 17, 2022He Wei-Wu · director, 10 percent owner, officer: Chairman and CEOPurchase50,000$3.18
Jun 17, 2022He Wei-Wu · officer: Chairman and CEOPurchase2,096$3.06
Jun 17, 2022He Wei-Wu · director, 10 percent owner, officer: Chairman and CEOPurchase36,058$2.97
May 26, 2022Zhou Quan · directorA-Award380,645$0.47
May 26, 2022Huang James · director: A-Award397,419$0.00
May 26, 2022Wu Yue Alexander · director: A-Award388,387$0.00
May 26, 2022Salisbury Franklin Cary jr · director: A-Award388,387$0.00
May 26, 2022SHROTRIYA RAJESH C MD · director: A-Award345,806$0.00
Dec 6, 2021Zukiwski Alexander A · officer: Chief Medical OfficerA-Award500,000$0.87
Nov 19, 2021He Wei-Wu · director, officer: Chairman and CEOPurchase200,000$0.98
Aug 20, 2021He Wei-Wu · director, officer: Chairman and CEOPurchase180,000$1.26
Aug 20, 2021He Wei-Wu · director, officer: Chairman and CEOPurchase300,000$1.29
Jul 26, 2021Zhang Larry · officer: PresidentA-Award800,000$1.28
Jun 16, 2021Zhou Quan · directorA-Award108,257$1.65
Jun 16, 2021Wu Yue Alexander · directorA-Award110,459$1.65
Jun 16, 2021SHROTRIYA RAJESH C MD · directorA-Award98$1.65
Jun 16, 2021Salisbury Franklin Cary jr · directorA-Award110,459$1.65
Jun 16, 2021Huang James · directorA-Award113,028$1.65
Jun 16, 2021He Wei-Wu · director, 10 percent owner, officer: Chairman and CEOA-Award4,000,000$1.73
Mar 30, 2021He Wei-Wu · director, officer: Chairman and CEOPurchase3,000,000$2.05
Dec 18, 2020Xu Weihao · officer: Chief Financial OfficerA-Award800,000$2.61
Dec 18, 2020Xu Weihao · officer: Chief Financial OfficerPurchase2,279$2.63
Dec 18, 2020Xu Weihao · officer: Chief Financial OfficerPurchase1,721$2.64
Dec 18, 2020Xu Weihao · officer: Chief Financial OfficerPurchase2,000$2.44
Nov 24, 2020He Wei-Wu · director, officer: Chairman and CEOPurchase100,000$2.18
Institutional positioning

13F filings over the trailing two quarters

New 0Increased 0Reduced 0Sold out 2
FilerActionSharesFiled
MORGAN STANLEYSold Out0May 27, 2026
SIMPLEX TRADING, LLCSold Out0May 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 9, 2022